These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6018478)

  • 21. Therapy-resistant haemarthros in a patient with factor VIII inhibitor: successful treatment with recombinant factor VIIa.
    Lenz E; Repas-Humpe M; Oldenburg J; Kreuz W; Schröter W; Eber SW
    Eur J Pediatr; 1999 Nov; 158(11):951-2. PubMed ID: 10541960
    [No Abstract]   [Full Text] [Related]  

  • 22. Right elbow arthropathy in a patient with severe haemophilia A.
    Ferretti A; Baldacci E; Chistolini A; Santoro C
    Br J Haematol; 2020 Aug; 190(4):484. PubMed ID: 32383238
    [No Abstract]   [Full Text] [Related]  

  • 23. Lower doses of factor VIII for hemophilia.
    Penner JA; Kelly PE
    N Engl J Med; 1977 Aug; 297(7):401. PubMed ID: 876340
    [No Abstract]   [Full Text] [Related]  

  • 24. An uncommon cause of knee haemarthrosis in an adult haemophilia patient suffering from long-term paraplegia.
    Rodriguez-Merchan EC; Jimenez-Yuste V; Valentino LA
    Haemophilia; 2011 Sep; 17(5):e845-6. PubMed ID: 21682822
    [No Abstract]   [Full Text] [Related]  

  • 25. [Epidemiology and characteristics of hemophilia in Bulgaria].
    Anastassov A; Tankovski I; Nigno C; Guénova V; Lissitchkov T
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(1):113-8. PubMed ID: 4110776
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of intramuscular hemorrhages in hemophilic patients].
    Battistella LR; Imamura ST
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(1):15-7. PubMed ID: 3933080
    [No Abstract]   [Full Text] [Related]  

  • 27. The safety and efficacy of B-domain deleted recombinant factor VIII concentrates in patients with severe haemophilia A: an update.
    Lusher JM; Roth DA
    Haemophilia; 2005 May; 11(3):292-3. PubMed ID: 15876278
    [No Abstract]   [Full Text] [Related]  

  • 28. Musculoskeletal bleeding in hemophilia.
    Greer RB; Ballard JO
    Pediatr Ann; 1982 Jun; 11(6):521-4, 526-7. PubMed ID: 6808447
    [No Abstract]   [Full Text] [Related]  

  • 29. Prophylaxis and complications in hemophilia. Introductory remarks.
    Harris CE
    Bibl Haematol; 1970; 34():97-103. PubMed ID: 5436358
    [No Abstract]   [Full Text] [Related]  

  • 30. [The prevention of joint hemorrhages in Hemophilia A].
    van Creveld S; McEwan-Van der Horst ; Frese-Vorstelman DL
    Maandschr Kindergeneeskd; 1968 Dec; 36(8):253-9. PubMed ID: 5715995
    [No Abstract]   [Full Text] [Related]  

  • 31. Radiation therapy in pseudotumour haemarthrosis.
    Lal P; Biswal BM; Thulkar S; Patel AK; Venkatesh R; Julka PK
    Australas Radiol; 1998 Nov; 42(4):344-6. PubMed ID: 9833373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical orthopedic correction of hemophilic hemarthrosis at Ramathibodi Hospital.
    Isarangkura P; Keorochana S; Chuansumrit A; Jitpraphai C; Mahaphan W; Hathirat P; Chiewsilp P; Prachathumrong P; Pintadit P; Panthangkura W
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():253-5. PubMed ID: 7886589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled trial of joint aspiration in acute haemophilic haemarthrosis.
    Ingram GI; Mathews JA; Bennett AE
    Ann Rheum Dis; 1972 Sep; 31(5):423. PubMed ID: 5071639
    [No Abstract]   [Full Text] [Related]  

  • 34. Arthropathy and substitution therapy.
    Aledort LM
    Haemostasis; 1992; 22(5):245-6. PubMed ID: 1478534
    [No Abstract]   [Full Text] [Related]  

  • 35. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
    Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
    Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ;
    Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying and overcoming barriers to prophylaxis in the management of haemophilia.
    Petrini P
    Haemophilia; 2007 Sep; 13 Suppl 2():16-22. PubMed ID: 17685919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of hemophilia].
    De Tezanos Pinto M
    Medicina (B Aires); 1968 Dec; 28():Suppl 1:27-33. PubMed ID: 5730274
    [No Abstract]   [Full Text] [Related]  

  • 39. Surgical management of musculoskeletal problems in hemophilia.
    Wilson FC; Mahew DE; McMillan CW
    Instr Course Lect; 1983; 32():233-41. PubMed ID: 6443731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of haemophilic synovitis: clinical aspects.
    Hoots WK; Rodriguez N; Boggio L; Valentino LA
    Haemophilia; 2007 Nov; 13 Suppl 3():4-9. PubMed ID: 17822514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.